Integral Health Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-72,500
Closed -$8.37M 87
2020
Q4
$8.37M Buy
72,500
+7,500
+12% +$840K 2.49% 16
2020
Q3
$6.33M Sell
65,000
-10,000
-13% -$1.15M 1.94% 16
2020
Q2
$9.2M Hold
75,000
2.76% 7
2020
Q1
$6.57M Buy
75,000
+55,000
+275% +$5.82M 2.89% 13
2019
Q4
$2.09M Buy
+20,000
New +$2.24M 0.81% 35

Other funds holding GWPH

Integral Health Asset Management's GWPH Position: Q1 2021 in Review

Integral Health Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 72,500 shares — an estimated $8.37M sold.

Integral Health Asset Management first reported a position in GWPH in Q4 2019 and held it in 5 quarters. The position peaked at $9.2M in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Integral Health Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Integral Health Asset Management sold 72,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $8.37M.
  • Integral Health Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 5 quarters.
  • Integral Health Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.2M in Q2 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Integral Health Asset Management's 13F filing for Q1 2021, filed 10 May 2021.